Poxel S.A. (LON:0RA2)
London · Delayed Price · Currency is GBP · Price in EUR 0.2840
-0.0170 (-5.65%)
At close: Feb 11, 2026
Poxel Market Cap
Poxel has a market cap or net worth of 13.2 million as of February 12, 2026. Its market cap has increased by 4.42% in one year.
Market Cap
13.20M
Enterprise Value
65.43M
Revenue
6.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
Market Cap Chart
Since February 6, 2015, Poxel's market cap has decreased from 143.45M to 13.20M, a decrease of -90.80%. That is a compound annual growth rate of -19.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 13.20M | 20.35% |
| Dec 31, 2025 | 10.97M | 78.55% |
| Dec 31, 2024 | 6.14M | -63.60% |
| Dec 29, 2023 | 16.87M | -29.96% |
| Dec 30, 2022 | 24.09M | -79.64% |
| Dec 31, 2021 | 118.34M | -26.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 28.70M |
| Aptamer Group | 25.62M |
| Sareum Holdings | 23.47M |
| Fusion Antibodies | 19.07M |
| Oxford BioDynamics | 12.01M |
| Genflow Biosciences | 10.36M |
| IXICO | 9.50M |
| OptiBiotix Health | 7.64M |